FDAnews Drug Daily Bulletin

TARGENT INC. ANNOUNCES RESIGNATION OF CEO

July 10, 2006
A A

With the acquisition of Targent Incorporated's oncology assets by Spectrum Pharmaceuticals Inc., Irvine, California, Targent announced that Patrick Maguire, MD, PhD, has resigned as Chief Executive Officer and Director. Dr. Maguire, 52, will pursue other business opportunities. He currently serves as a Director of Hemolife Medical Inc. in San Clemente, California. BioSpace (http://www.biospace.com/news_story.aspx?StoryId=23552)